Target intelligence / Profile preview

MT-CO1 pseudogene 48 (MTCO1P48)

Target
MTCO1P48
Molecular classification
Pseudogene, Other (non-coding sequence)
01

Overview

MT-CO1 pseudogene 48 (MTCO1P48) refers to a non-functional sequence in the human genome derived from the MT-CO1 gene, which encodes cytochrome c oxidase subunit I. Pseudogenes are typically non-coding remnants of genes that have accumulated mutations rendering them inactive; they do not produce functional proteins or perform cellular functions. There are numerous MT-CO1 pseudogenes (MTCO1P1, MTCO1P2, ..., MTCO1P48) catalogued in genomic databases, but they are not therapeutic targets and have no established biological or clinical relevance[3][5]. MTCO1P48 is often listed simply as a genomic locus; structured databases (HGNC, Ensembl, GeneCards) do not assign functional data or target status to it. Pseudogenes such as MTCO1P48 are distinct from the protein-coding MT-CO1 gene, which does play important roles in mitochondrial function and is implicated in various diseases[1][4]. The pseudogene itself should not be mistaken for the functional MT-CO1 gene. MTCO1P48 is not a therapeutically actionable target, is not a receptor, enzyme, transporter, nor does it fulfill canonical roles in biological pathways. Its assignment as a drug target would be incorrect, and the entry should be flagged as non-canonical in any structured target database.

Other names
MTCO1P48mitchondrially encoded cytochrome c oxidase I pseudogene 48
02

Mechanism of action

None (pseudogenes do not produce functional proteins; no drug mechanism described for this sequence)

03

Biological functions

No known biological function (pseudogenes generally do not code for functional proteins)[5]Not involved in canonical metabolic or signaling processes
04

Disease associations

Not implicated in disease directlyNo evidence of involvement in cancer, inflammation, neurodegenerative, cardiovascular, or infectious disease for MTCO1P48 pseudogene itself. Note: MT-CO1 (the actual gene) is associated with numerous diseases, but this does not apply to the pseudogene[1][4]
05

Safety considerations

None documented; not a therapeutic target
06

Interacting drugs

None (no known drugs interact with this pseudogene)
07

Biomarkers

None known; not used for patient selection or efficacy monitoring

Beyond the preview

Go deeper on MT-CO1 pseudogene 48 (MTCO1P48).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MT-CO1 pseudogene 48 (MTCO1P48).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call